
AMD has announced a deal to acquire programmable chipmaker Xilinx for US$35 billion to establish what CEO Lisa Su said will be “the industry’s high-performance computing leader.”
The Santa Clara, California-based company’s Tuesday, October 27, announcement marks yet another tectonic shift in the semiconductor industry following Nvidia’s announcement in September that it plans to buy British chip designer Arm for US$40 billion.
The all-stock deal, which represents approximately US$143 per share of Xilinx common stock, has been approved by the boards of directors of both AMD and Xilinx, and it’s expected to close in late 2021 if it gets approved by regulators and meets other closing conditions, reported CRN.
Su will serve as CEO of the combined company, while Xilinx President and CEO Victor Peng will be responsible for the Xilinx business and strategic growth initiatives. AMD will also add two Xilinx directors to its board of directors.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas